NZ229806A - Pyranone derivatives and pharmaceutical compositions thereof - Google Patents

Pyranone derivatives and pharmaceutical compositions thereof

Info

Publication number
NZ229806A
NZ229806A NZ229806A NZ22980689A NZ229806A NZ 229806 A NZ229806 A NZ 229806A NZ 229806 A NZ229806 A NZ 229806A NZ 22980689 A NZ22980689 A NZ 22980689A NZ 229806 A NZ229806 A NZ 229806A
Authority
NZ
New Zealand
Prior art keywords
hydroxy
oxo
ethyl
pyran
tetrahydro
Prior art date
Application number
NZ229806A
Other languages
English (en)
Inventor
Henry Joshua
Kenneth E Wilson
Michael S Schwartz
Jyh Lee Ta
Gerald E Stokker
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/363,792 external-priority patent/US4968693A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NZ229806A publication Critical patent/NZ229806A/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
NZ229806A 1989-06-09 1989-07-04 Pyranone derivatives and pharmaceutical compositions thereof NZ229806A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/363,792 US4968693A (en) 1988-03-02 1989-06-09 3-keto HMG-COA reductase inhibitors

Publications (1)

Publication Number Publication Date
NZ229806A true NZ229806A (en) 1991-12-23

Family

ID=23431752

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ229806A NZ229806A (en) 1989-06-09 1989-07-04 Pyranone derivatives and pharmaceutical compositions thereof

Country Status (14)

Country Link
JP (1) JPH0324033A (ja)
CN (1) CN1047863A (ja)
AU (1) AU618106B2 (ja)
CA (1) CA1328877C (ja)
DK (1) DK330389A (ja)
FI (1) FI893272A (ja)
HU (1) HUT54133A (ja)
IE (1) IE892191L (ja)
IL (1) IL90847A0 (ja)
NO (1) NO892761L (ja)
NZ (1) NZ229806A (ja)
PT (1) PT91204B (ja)
YU (1) YU144589A (ja)
ZA (1) ZA895140B (ja)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668699A (en) * 1985-08-05 1987-05-26 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
PT85109A (en) * 1986-06-23 1987-07-01 Merck & Co Inc Process for the preparation of hydroxy-tetrahydropyranone derivatives or corresponding ring opened dihydroxy acids which are hmg-coa reductase inhibitors
US5073568A (en) * 1988-11-14 1991-12-17 Hoffmann-La Roche Inc. Antipsoriatic agents

Also Published As

Publication number Publication date
NO892761L (no) 1990-12-10
CA1328877C (en) 1994-04-26
NO892761D0 (no) 1989-07-04
PT91204B (pt) 1995-03-31
CN1047863A (zh) 1990-12-19
DK330389D0 (da) 1989-07-04
DK330389A (da) 1990-12-10
JPH0324033A (ja) 1991-02-01
YU144589A (en) 1990-12-31
ZA895140B (en) 1990-03-28
AU618106B2 (en) 1991-12-12
HUT54133A (en) 1991-01-28
IE892191L (en) 1990-12-09
IL90847A0 (en) 1990-02-09
FI893272A (fi) 1990-12-10
FI893272A0 (fi) 1989-07-05
PT91204A (pt) 1991-02-08
AU3783889A (en) 1990-12-13

Similar Documents

Publication Publication Date Title
US5021453A (en) 3-keto HMG-CoA reductase inhibitors
US4968693A (en) 3-keto HMG-COA reductase inhibitors
US4940727A (en) Novel HMG-CoA reductase inhibitors
US5116870A (en) HMG-CoA reductase inhibitors
US4450171A (en) Antihypercholesterolemic compounds
US4444784A (en) Antihypercholesterolemic compounds
EP0033538B1 (en) 6(r)-(2-(8'-acyloxy-2'-methyl-6'-methyl (or hydrogen)-polyhydronaphthyl-1')-ethyl)-4(r)-hydroxy-3,4,5,6-tetrahydro-2h-pyran-2-ones, the hydroxy acid form of said pyranones, the pharmaceutically acceptable salts of said hydroxy acids, and the lower alkyl, and phenyl, dimethylamino or acetylamino substituted lower alkyl esters of said hydroxy acid, processes for preparing the same, and a pharmaceutical antihypercholesterolemic composition containing the same
EP0251625B1 (en) Novel hmg-coa reductase inhibitors
US5102911A (en) 4-Substituted HMG-CoA reductase inhibitors
US4963538A (en) 5-oxygenated HMG-CoA reductase inhibitors
US5130306A (en) 5-Oxygenated HMG-COA reductase inhibitors
US5098931A (en) 7-substituted HMG-CoA reductase inhibitors
US4970231A (en) 4-substituted HMG-CoA reductase inhibitors
US5010105A (en) Antihypercholesterolemic compounds
USRE36481E (en) HMG-CoA reductase inhibitors
EP0349063A2 (en) 5-oxygenated HMG-COA reductase inhibitors
US4795811A (en) Intermediates for preparing HMG-CoA reductase inhibitors
US5041562A (en) 3-keto HMG-CoA reductase inhibitors
EP0409399B1 (en) 3-keto HMG-COA reductase inhibitors
US5001241A (en) 3-KETO HMG-CoA reductase inhibitors
EP0415488A2 (en) 7-Substituted HMG-COA reductase inhibitors
AU618106B2 (en) 3-keto-naphtylethyl substituted pyran-2-ones and equilavent hydroxy acids
EP0306263B1 (en) Novel hmg-coa reductase inhibitors
JP2582785B2 (ja) 新規ＨＭＧ−ＣｏＡレダクタ−ゼ阻害剤
US4937259A (en) Antihypercholesterolemic compounds